News - Quintiles

Filter

Current filters:

Quintiles

Popular Filters

Therapeutic effects of Eisai's lenvatinib in melanoma confirmed

12-06-2013

Japanese drug major Eisai (TYO: 4523) says that the therapeutic effects of lenvatinib, a VEGF receptor…

EisailenvatinibOncologyPharmaceuticalQuintilesResearch

Merck Serono and Quintiles enter novel clinical development partnership

16-05-2013

Merck Serono, the biotech division of Germany's Merck KGaA (MRK: DE) and Quintiles (NYSE: Q) have announced…

BiotechnologyMerck KGaAMerck SeronoPharmaceuticalQuintilesResearch

Importance of early planning in pharma market access in Europe

15-11-2012

With payers playing an increasingly critical role in physician prescribing practices across Europe, regulatory…

EuropeMarkets & MarketingPharmaceuticalQuintilesRegulation

Sinclair IS partners with Quintiles to commercialize portfolio in Mexico

13-09-2012

UK-based Sinclair IS Pharma (AIM: SPH.L) yesterday announced the signing of a 10-year collaboration and…

DermatologicalsLicensingMarkets & MarketingPharmaceuticalQuintilesSinclair IS PharmaSouth America

Quintiles expands operations in China

18-06-2012

US-headquartered biopharma services provider Quintiles yesterday announced agreements to establish a…

Asia-PacificBiotechnologyFinancialPharmaceuticalQuintilesResearch

Quintiles to expand clinical development capabilities in Russia

26-02-2012

Biopharmaceutical services company Quintiles is moving further into emerging markets, last week signing…

EuropePharmaceuticalQuintilesRegulationResearchRVC Biofund

Quintiles expands in MENA pharma markets

16-02-2012

Biopharmaceutical services company Quintiles is extending its global footprint to provide commercial…

Dayarn PharmaMarkets & MarketingPharmaceuticalQuintilesRegulationRest of the World

Drug approval and launch for Novartis in China, where Quintiles expands

18-01-2012

Swiss drug major Novartis (NOVN: VX) says it has received regulatory approval in China from the State…

Asia-PacificDiabetesGalvusLucentisMarkets & MarketingNovartisOphthalmicsPharmaceuticalQuintilesRegulationResearch

Key considerations for successful biosimilar development viewed by Quintiles

03-10-2011

Regulatory and commercial considerations are the primary drivers for successful biosimilar clinical development,…

BiotechnologyGenericsGlobalQuintilesRegulationResearch

Back to top